As I understand it, it's not dopamine that is damaging to the serotonin neuron, it's the oxidized metabolite of dopamine that's damaging to the serotonin neuron. That is why MAO-B inhibitors have shown to be able to completely block MDMA-induced neurotoxicity, right?
I have also read that MDAI is non-neurotoxic because it does not act as a dopamine releasing agent so there isn't a flood of oxidized dopamine damaging the serotonin neuron. The downside is that most people find MDAI a lot less enjoyable than MDMA, because apparently dopamine does contribute a lot to the experience. However, if you combine MDAI with a stimulant, people say it feels a lot like MDMA, but then it's neurotoxic again.
So does an MAO-B inhibitor, like selegiline, have a stimulant effect without the oxidative stress?
If so, could MDAI combined with selegiline be very similar MDMA, but without the oxidative stress?
I have also read that MDAI is non-neurotoxic because it does not act as a dopamine releasing agent so there isn't a flood of oxidized dopamine damaging the serotonin neuron. The downside is that most people find MDAI a lot less enjoyable than MDMA, because apparently dopamine does contribute a lot to the experience. However, if you combine MDAI with a stimulant, people say it feels a lot like MDMA, but then it's neurotoxic again.
So does an MAO-B inhibitor, like selegiline, have a stimulant effect without the oxidative stress?
If so, could MDAI combined with selegiline be very similar MDMA, but without the oxidative stress?
